Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126682811 | 12668281 | 1 | I | 20160808 | 20160819 | 20160819 | EXP | HK-TEVA-685248ISR | TEVA | YEUNG TLM, LI PSH, LI KKW. PRESUMED TOPIRAMATE RETINOPATHY: A CASE REPORT. JOURNAL OF MEDICAL CASE REPORTS. 2016; 10(1): ARTICLE NUMBER 210 | 48.00 | YR | F | Y | 0.00000 | 20160819 | MD | HK | HK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126682811 | 12668281 | 1 | PS | TOPIRAMATE. | TOPIRAMATE | 1 | 200 MILLIGRAM DAILY; | Y | 76317 | 100 | MG | BID | |||||||
| 126682811 | 12668281 | 2 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | 50 MILLIGRAM DAILY; | Y | 76317 | 25 | MG | BID | |||||||
| 126682811 | 12668281 | 3 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126682811 | 12668281 | 1 | Seizure |
| 126682811 | 12668281 | 2 | Seizure |
| 126682811 | 12668281 | 3 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126682811 | 12668281 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126682811 | 12668281 | Retinitis pigmentosa | |
| 126682811 | 12668281 | Toxicity to various agents | |
| 126682811 | 12668281 | Visual field defect |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |